Goldman Sachs maintains Clarivate at Neutral, lowers price target to $2.30 from $2.60
Goldman Sachs kept its Neutral rating on Clarivate but reduced its price target by 11.5% to $2.30, suggesting an 8.5% upside from the Nov 4 close of $2.12.
How this was made

The 30-second read
Why it matters
The target reduction could trigger short‑term sell‑offs and affect related ETFs holding CLV.
Market read
Analyst price‑target changes are a common catalyst for short‑term price moves in micro‑cap stocks.
What to watch
Potential upcoming contract wins or product launches that could offset the downgrade.
Background
Clarivate provides analytics and insights to research institutions; analyst coverage influences its valuation.
Market effects
May weigh on the information services sector as peers could face similar scrutiny.
Limited to US markets where Clarivate trades.
Minimal global impact beyond sector sentiment.
Counterpoint
Some investors may view the cut as an overreaction and see buying opportunity at lower valuations.
Key entities
- AnalystGoldman Sachs
Equity research firm issuing the target cut.
- CompanyClarivate
Provider of analytics and data services.
